US2011319450A1PendingUtilityA1
Benzimidazole compound crystal
Est. expiryJun 17, 2019(expired)· nominal 20-yr term from priority
A61P 31/04A61P 1/04A61P 1/00C07D 401/12A61K 31/4439C07B 2200/13A61K 31/415
61
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A novel crystal of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole or a salt thereof of the present invention is useful for an excellent antiulcer agent.
Claims
exact text as granted — not AI-modified1 - 7 . (canceled)
8 . A crystal of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole or a salt thereof which can retain a content exceeding 90% for up to 4 weeks when it is stored at 60° C. (exposed).
9 . A pharmaceutical composition which comprises the crystal of claim 8 , and a pharmaceutically acceptable excipient, carrier or diluent.
10 . The pharmaceutical composition of claim 9 , which is in a form selected from granules, capsules or orally disintegrating tablets.Join the waitlist — get patent alerts
Track US2011319450A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.